文献速递眼底病与葡萄膜炎

关于镇痛药与抗炎药在全视网膜光凝术中作用的综合荟萃分析

A Comprehensive Meta-Analysis on the Role of Analgesics and Anti-Inflammatories in Pan-Retinal Photocoagulation.
PubMed 文献 · Am J Ophthalmol · 2024-06-26

该系统综述与荟萃分析纳入13项随机对照试验、共1404只眼,比较镇痛药或非甾体抗炎药与安慰剂在糖尿病视网膜病变患者全视网膜光凝术中的镇痛效果;镇痛组疼痛敏感性显著低于安慰剂组(SMD -0.38;95%CI -0.58, -0.17;P < .01;I2 = 69%),全身给药与滴眼液给药亚组也均显著降低疼痛。

要点

  • 镇痛药或非甾体抗炎药较安慰剂显著降低全视网膜光凝术中的疼痛敏感性(SMD -0.38;95%CI -0.58, -0.17;P < .01)。
  • 全身给药亚组(SMD -0.28;95%CI -0.50, -0.07;P < .01;I2 = 43%)与单纯滴眼液亚组(SMD -0.46;95%CI -0.88, -0.05;I2 = 83%)均显著降低疼痛敏感性。
  • 作者结论认为全身镇痛在对比安慰剂时可能优于局部给药。

核心结论

  • 荟萃分析结果显示,使用镇痛药可显著降低全视网膜光凝术中的疼痛敏感性,且全身镇痛在对比安慰剂时可能优于局部给药。

研究设计与样本

  • 系统综述与荟萃分析,按PRISMA指南检索PubMed、Embase和Cochrane中央对照试验注册库,纳入因糖尿病视网膜病变接受全视网膜光凝术、比较镇痛药或非甾体抗炎药与安慰剂的随机对照试验,共13项研究、1404只眼,其中9项为交叉试验。

主要发现

  • 镇痛组疼痛敏感性显著低于安慰剂组(SMD -0.38;95%CI -0.58, -0.17;P < .01;I2 = 69%)。
  • 全身给予镇痛药或非甾体抗炎药(包括安乃近、恩托诺克斯、对乙酰氨基酚、布洛芬、咖啡因、甲芬那酸、肌内注射酮咯酸氨丁三醇和双氯芬酸钾)亚组较安慰剂显著降低疼痛(SMD -0.28;95%CI -0.50, -0.07;P < .01;I2 = 43%)。
  • 单纯滴眼液给药(酮咯酸氨丁三醇0.5%和双氯芬酸钠0.1%)亚组疼痛敏感性也有显著差异(SMD -0.46;95%CI -0.88, -0.05;I2 = 83%),但异质性更大。

关键数值与推荐

  • 疼痛采用视觉模拟量表评估,偏倚风险采用Cochrane协作组随机对照试验偏倚风险工具第2版及其交叉试验版本评估,证据确定性采用GRADE工具测量。
  • 共纳入13项随机对照试验、1404只眼,其中9项为交叉试验。

临床怎么用

  • 作者结论认为,包含超过1000例患者的荟萃分析显示使用镇痛药可显著降低全视网膜光凝术中的疼痛敏感性,且全身镇痛对比安慰剂时可能优于局部给药。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Pan-retinal photocoagulation (PRP) is the mainstay of treatment for proliferative diabetic retinopathy (PDR), reducing the risk of severe vision loss. Pain poses a potential obstacle to effective laser delivery and patient compliance. Therefore, implementing pain relief strategies can enhance both treatment efficacy and patient comfort. DESIGN: A systematic review and meta-analysis. METHODS: We conducted a systematic review and meta-analysis according to PRISMA guidelines. The PubMed, Embase and Cochrane Central Register of Controlled Trials databases were searched for randomized controlled trials (RCTs) that enrolled patients undergoing PRP due to DR and compared analgesics or non-steroidal anti-inflammatory drugs (NSAID) to placebo. Pain was evaluated with the visual analogue scale. The version 2 of the Cochrane Collaboration's Risk of Bias in Randomized Controlled Trials tool and its version for crossover trials were used to assess the risk of bias. The Grading of Recommendations, Assessment, Development, and Evaluation tool was used to measure the certainty of evidence. RESULTS: A total of 13 studies were included, comprising 1404 eyes from RCTs, nine of which were crossover. Patients who were administered analgesia reported a significantly lower pain sensitivity compared to those who received placebo (Standardized mean difference [SMD] -0.38; 95% confidence interval [CI] -0.58, -0.17; P < .01; I2 = 69%). Subgroup analysis of systemic administration of analgesics/NSAIDs (metamizole, Entonox, acetaminophen, ibuprofen, caffeine, mefenamic acid, intramuscular ketorolac tromethamine, and potassium diclofenac) also showed a statistically significant reduction in pain when compared to placebo (SMD -0.28; 95% CI -0.50, -0.07; P < .01; I2 = 43%). Exclusive eye drops administration (ketorolac tromethamine 0.5% and sodium diclofenac 0.1%) also showed a significant difference in pain sensitivity (SMD -0.46; 95% CI -0.88, -0.05; I2 = 83%), however with a more significant heterogeneity. CONCLUSIONS: The results of this meta-analysis including over 1000 patients demonstrated that the use of analgesics significantly reduced pain sensitivity during PRP, and systemic analgesia is potentially better than topical administration when compared to placebo.

来源:Am J Ophthalmol,查看原文。版权归原作者所有。

引用

  1. Arruda MP, Lima RV, Hira S, et al. A Comprehensive Meta-Analysis on the Role of Analgesics and Anti-Inflammatories in Pan-Retinal Photocoagulation. Am J Ophthalmol. 2024. PMID: 38942228. doi:10.1016/j.ajo.2024.06.018

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。